SR

Srinivas Rao

CB Cypress Bioscience: 7 patents #1 of 10Top 10%
AT Atai Therapeutics: 2 patents #4 of 18Top 25%
CP Collegium Pharmaceutical: 2 patents #12 of 16Top 75%
📍 Columbia, MD: #26 of 1,501 inventorsTop 2%
🗺 Maryland: #730 of 35,612 inventorsTop 3%
Overall (All Time): #142,053 of 4,157,543Top 4%
27
Patents All Time

Issued Patents All Time

Showing 1–25 of 27 patents

Patent #TitleCo-InventorsDate
12281336 Chikungunya virus (CHIKV) virus-like particles (VLPS) comprising the C, E1, and E2 structural proteins Gary J. Nabel, Wataru Akahata 2025-04-22
12168675 Virus-like particles and methods of use Gary J. Nabel, Wataru Akahata 2024-12-17
12128027 N—N-dimethyltryptamine (DMT) and DMT analog compositions, methods of making, and methods of use thereof Glen Short, Majed Fawaz, Prerak Patel, Santnu Patel 2024-10-29
12065405 Prodrugs and conjugates of dimethyltryptamine Robert B. Perni, Glenn SHORT, Tanweer A. Khan 2024-08-20
11992523 Method for producing chikungunya virus (CHIKV) virus-like particles comprising the C, E2, and E1 structural proteins Gary J. Nabel, Wataru Akahata 2024-05-28
11845736 Prodrugs of MDMA, MDA, and derivatives thereof Glenn SHORT, Robert B. Perni, Tanweer A. Khan, Alan C. Gibbs 2023-12-19
11718647 Virus-like particles and methods of use Gary J. Nabel, Wataru Akahata 2023-08-08
11643391 Prodrugs and conjugates of dimethyltryptamine Robert B. Perni, Glenn SHORT, Tanweer A. Khan 2023-05-09
11602521 N,N-dimethyltryptamine compositions and methods Glenn SHORT 2023-03-14
11369674 Treatment method utilizing chikungunya virus (CHIKV) virus-like particles (VLPS) comprising the C, E2 and E1 structural proteins Gary J. Nabel, Wataru Akahata 2022-06-28
11098084 Virus-like particles and methods of use Gary J. Nabel, Wataru Akahata 2021-08-24
10369208 Methods for the induction of immune responses in a subject compromising administering virus-like particles (VLPS) prepared from Chikungunya virus structural proteins Gary J. Nabel, Wataru Akahata 2019-08-06
10227314 Cystathionine-gamma-lyase (CSE) inhibitors Sergio G. Duron, Justin Chapman, Simon G. Sydserff, Gregory Stein 2019-03-12
10138277 Virus-like particles and methods of use Gary J. Nabel, Wataru Akahata 2018-11-27
9771339 Cystathionine-γ-lyase (CSE) inhibitors Sergio G. Duron, Justin Chapman, Simon G. Sydserff, Gregory Stein 2017-09-26
9725426 Cystathionine-γ-lyase (CSE) inhibitors Sergio G. Duron, Justin Chapman, Simon G. Sydserff, Gregory Stein, Warren Wade 2017-08-08
9487563 Virus-like particles and methods of use Gary J. Nabel, Wataru Akahata 2016-11-08
9353353 Virus-like particles (VLPs) prepared from chikungunya virus structural proteins Gary J. Nabel, Wataru Akahata 2016-05-31
8021687 Modified release compositions of milnacipran Jane Hirsh, Roman V. Rariy, Shubha Chungi, Michael Heffernan 2011-09-20
7994220 Milnacipran for the long-term treatment of fibromyalgia syndrome Michael Gendreau, Jay Kranzler 2011-08-09
7915246 Methods of treating fibromyalgia syndrome, chronic fatigue syndrome and pain Jay Kranzler 2011-03-29
7888342 Methods of treating fibromyalgia syndrome, chronic fatigue syndrome and pain Jay Kranzler 2011-02-15
7820643 Methods of treating fibromyalgia syndrome, chronic fatigue syndrome and pain Jay Kranzler 2010-10-26
7704527 Modified release compositions of milnacipran Jane Hirsh, Roman V. Rariy, Shubha Chungi, Michael Heffernan 2010-04-27
6992110 Methods of treating fibromyalgia syndrome, chronic fatigue syndrome and pain Jay Kranzler 2006-01-31